RESUMO
A significant development in the design of a NiCo2 S4 3D hierarchical hollow nanoarrow arrays (HNA)-based supercapacitor binder free electrode assembled by 1D hollow nanoneedles and 2D nanosheets on a Ni foam collector through controlling ionic liquid 1-octyl-3-methylimidazolium chloride ([OMIm]Cl) concentration is reported. The unique NiCo2 S4 -HNA electrode acquires high specific capacity (1297 C g-1 at 1 A g-1 , 2.59 C cm-2 at 2 mA cm-2 ), excellent rate capability (maintaining 73.0% at 20 A g-1 ), and long operational life (maintaining 92.4% after 10 000 cycles at 5 A g-1 ), which are superior to those for 1D hollow nanoneedle arrays (HNN) and 2D porous nanoflake arrays (PNF). The outstanding electrochemical performance is attributed to the novel 3D structure with large specific surface, hollow cores, high porosity as well as stable architecture. In addition, a hybrid supercapacitor applying 3D NiCo2 S4 -HNA as the positive electrode and active carbon as the negative electrode exhibits a high energy density of 42.5 Wh kg-1 at a power density of 2684.2 W kg-1 in an operating voltage of 1.6 V. Robust cycling stability is also expressed with 84.9% retention after repeating 10 000 cycles at 5 A g-1 , implying their great potential in superior-performance supercapacitors.
RESUMO
The treatment of patients with metastatic prostate cancer (PCa) is considered to be a longstanding challenge. Conventional treatments for metastatic PCa, such as radical prostatectomy, radiotherapy and androgen receptortargeted therapy, induce senescence of PCa cells to a certain extent. While senescent cells can impede tumor growth through the restriction of cell proliferation and increasing immune clearance, the senescent microenvironment may concurrently stimulate the secretion of a senescenceassociated secretory phenotype and diminish immune cell function, which promotes PCa recurrence and metastasis. Resistance to established therapies is the primary obstacle in treating metastatic PCa as it can lead to progression towards an incurable state of disease. Therefore, understanding the molecular mechanisms that underly the progression of PCa is crucial for the development of novel therapeutic approaches. The present study reviews the phenomenon of treatmentinduced senescence in PCa, the dual role of senescence in PCa treatments and the mechanisms through which senescence promotes PCa metastasis. Furthermore, the present review discusses potential therapeutic strategies to target the aforementioned processes with the aim of providing insights into the evolving therapeutic landscape for the treatment of metastatic PCa.
Assuntos
Senescência Celular , Metástase Neoplásica , Neoplasias da Próstata , Microambiente Tumoral , Humanos , Masculino , Neoplasias da Próstata/patologia , Neoplasias da Próstata/metabolismo , Neoplasias da Próstata/terapia , Animais , Proliferação de CélulasRESUMO
Uniform FeS1.4(Dmim)0.5 (Dmim = 1-n-butyl-2,3-dimethylimidazolium cation) hybrid nanosheets were developed through an innovative combination-decomposition approach. More importantly, the obtained hybrid nanosheets demonstrate unprecedentedly high electrocatalytic activity, which represents the discovery of a novel, efficient Fe-based electrocatalyst and expands the scope of new types of electrolytic water oxidation.
RESUMO
The detection of vitality of wounds is very important in forensic practice. This study is performed using quantitative real-time reverse transcriptase polymerase chain reaction (RT-qPCR) in both mouse and human skin wounds for the application of IL-6 and IL-20 in order to differentiate intravital wounds from postmortem wounds. RT-qPCR analysis of contused mouse skin showed that increased IL-6 and IL-20â¯mRNA levels were found in comparison to intact skin tissues. The increased mRNA expressions of IL-6 and IL-20 were observed until 72â¯h after death in contused mouse skin, whereas there were no marked changes in these two cytokines in the postmortem contusion group. The alterations of IL-6 and IL-20 can also be detected in human skin wound samples. These finding suggest that mRNA levels of IL-6 and IL-20 might be used as potential markers for vital reaction.
Assuntos
Contusões/metabolismo , Interleucina-6/metabolismo , Interleucinas/metabolismo , Mudanças Depois da Morte , Pele/metabolismo , Adolescente , Adulto , Animais , Biomarcadores/metabolismo , Feminino , Patologia Legal , Humanos , Interleucina-6/genética , Interleucinas/genética , Masculino , Camundongos Endogâmicos BALB C , Pessoa de Meia-Idade , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase em Tempo Real , Pele/lesões , Adulto JovemRESUMO
A novel antioxidant polysaccharide-peptide complex LB-1b from the fruiting bodies of the edible abalone mushroom (Pleurotus abalonus) was purified and identified. The structural characteristic of LB-1b was identified by FTIR (Fourier-transform IR), 13C NMR and 1H NMR spectroscopy. LB-1b is a polysaccharide-peptide complex that contains glucose, rhamnose, glucuronic acid and galactose in the molar ratio of 22.4:1:1.7:1.6 and the N-terminal sequence of its peptide moiety has also been determined. The N-terminal amino acid sequence of LB-1b, IPKERKEFQQAQHLK, showed some resemblance to antioxidant enzymes. LB-1b exhibited high antioxidant activity in erythrocyte haemolysis in vitro and the anti-proliferative activity towards hepatoma HepG2 cells and breast cancer MCF7 cells with an IC50 of 24 and 14 µM respectively. LB-1b also demonstrated hypoglycaemic activity in drug-induced diabetic mice and anti-HIV-1 RT (reverse transcriptase) with an IC50 value of 12.5 µM.
Assuntos
Antineoplásicos/isolamento & purificação , Antioxidantes/isolamento & purificação , Carpóforos/química , Proteínas Fúngicas/isolamento & purificação , Glicoproteínas/isolamento & purificação , Hipoglicemiantes/isolamento & purificação , Pleurotus/química , Sequência de Aminoácidos , Animais , Antineoplásicos/química , Antineoplásicos/farmacologia , Antioxidantes/química , Antioxidantes/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Eritrócitos/efeitos dos fármacos , Proteínas Fúngicas/química , Proteínas Fúngicas/farmacologia , Glicoproteínas/química , Glicoproteínas/farmacologia , Hemólise , Humanos , Hipoglicemiantes/química , Hipoglicemiantes/farmacologia , Camundongos , Dados de Sequência Molecular , Análise de Sequência de ProteínaRESUMO
OBJECTIVE: The intent of this study was to purify and characterize a polysaccharide named LA from the fruiting bodies of the edible mushroom Pleurotus abalones. METHODS: The 120-kDa polysaccharide was obtained by extraction with boiling water, ethanol precipitation, ion exchange chromatography on Diethylaminoethyl-cellulose and gel filtration on Sephadex G-200. KEY FINDINGS: The LA was composed of glucose, rhamnose, glucuronic acid, xylose, galactose and arabinose in the molar ratio of 26.3:2.7:1:1.4:1.8:1.2. The FITR and 1H-NMR spectrum of LA disclosed that it was a saccharide with an α-configuration. Its 13C-NMR spectrum revealed that its main chain was [â6)-α-D-Gly(1â]n. The LA exhibited antioxidant activities, especially in scavenging 1,1- diphenyl-2-picryl-hydrazyl radicals and hydroxyl radicals. It manifested antiproliferative activity towards breast cancer MCF7 cells with an IC50 of 3.7 µm, and also exerted some antiproliferative activity against HepG2 cells. It manifested a hypoglycemic action on diabetic mice. It inhibited HIV-1 reverse transcriptase with an IC50 of 8.7 × 10(-2) µm. CONCLUSIONS: The polysaccharide from the abalone mushroom.